Capitol Correspondence - 12.17.19

Senate Confirms New Head of Food and Drug Administration

Share this page

ANCOR has been monitoring the nomination process for the Administrator of the Food and Drug Administration (FDA) because we have long advocated for the FDA to finalize a rule it proposed to ban the use of electric shock devices on people with disabilities.

As reported by Politico Pro:

“The Senate today confirmed President Donald Trump’s nominee to lead the FDA, Texas oncologist and hospital administrator Stephen Hahn.

Senators voted 72-18 in support of Hahn, a relative unknown in Washington.

Hahn’s spot atop a vast federal agency that overseas food, drugs, medical devices, animal health, tobacco and cosmetics will mark his first foray into public service in a quarter-century. He’ll immediately be thrust into controversial political and public health issues, most notably how to regulate the booming e-cigarette industry amid an outbreak of serious lung illnesses associated with some electronic vaping products.


Hahn was chairman of the radiation oncology department at the University of Pennsylvania medical school for nine years until 2015, when he joined MD Anderson Cancer Center in Texas and rose to chief medical executive last year.”